TABLE 2 .
Summary of capsule-typing results based on country of isolation and associated clinical condition
| Country (no. of isolates) | No. of isolates from indicated clinical condition with indicated capsule type |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invasive |
Carrier |
Unknown |
|||||||||||||
| Total no. | a | b | c | d | Total no. | a | b | c | d | Total no. | a | b | c | d | |
| Spain (45) | 43 | 25 | 16 | 2 | 2 | 1 | 1 | ||||||||
| France (36) | 30 | 20 | 9 | 1 | 2 | 1 | 1 | 3 | 2 | 1 | |||||
| USA (28) | 18 | 12 | 6 | 2 | 1 | 1 | 8 | 5 | 3 | ||||||
| Canada (12) | 12 | 7a | 5 | ||||||||||||
| Iceland (12) | 12 | 3 | 7 | 2 | |||||||||||
| New Zealand (10) | 6 | 6 | 4 | 4 | |||||||||||
| Norway (3) | 2 | 2 | 1 | 1 | |||||||||||
| Switzerland (3) | 2 | 1 | 1 | 1 | 1 | ||||||||||
| Australia (1) | 1 | 1 | |||||||||||||
| Russia (1) | 1 | 1 | |||||||||||||
| Total (150) | 126 | 76 | 45 | 4 | 1 | 13 | 7 | 3 | 1 | 2 | 11 | 7 | 1 | 3 | |
a
Isolate CAN8 is nonencapsulated due to a truncated csaA gene but was included as a type a isolate for the purposes of this analysis.